YOUR BUSINESS AUTHORITY
Springfield, MO
Bayer AG shares were up 2.5% in premarket trading Wednesday after the company won its first trial over claims its Roundup weedkiller causes cancer.
A California jury ruled the herbicide was not a substantial cause of a child's rare form of non-Hodgkin lymphoma.
The verdict is the fourth involving Roundup and the first in favor of Bayer, Reuters reports.
Read more from Reuters.
Project work in Springfield corridor will continue into 2031.